Novartis rMenB±OMV NZ Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Novartis rMenB±OMV NZ Vaccine, covering 2014-03-11 to 2014-03-11. Get the full timeline:
Most recent: Clinical Trial Update: Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine [Phase 2]